SouthState Corp’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.82M | Sell |
89,438
-85,634
| -49% | -$4.65M | 0.16% | 115 |
|
|
2026
Q1 | $11M | Buy |
175,072
+6,736
| +4% | +$539K | 0.51% | 57 |
|
|
2025
Q4 | $16.1M | Sell |
168,336
-661
| -0.4% | -$64.8K | 0.72% | 42 |
|
|
2025
Q3 | $16.5M | Buy |
168,997
+1,670
| +1% | +$173K | 0.76% | 39 |
|
|
2025
Q2 | $18M | Buy |
167,327
+5,510
| +3% | +$558K | 0.79% | 36 |
|
|
2025
Q1 | $16.3M | Buy |
161,817
+1,107
| +0.7% | +$111K | 0.75% | 39 |
|
|
2024
Q4 | $14.4M | Buy |
160,710
+2,977
| +2% | +$262K | 0.94% | 30 |
|
|
2024
Q3 | $13.2M | Buy |
157,733
+1,097
| +0.7% | +$86.5K | 0.91% | 35 |
|
|
2024
Q2 | $12.1M | Buy |
156,636
+427
| +0.3% | +$31.3K | 0.88% | 34 |
|
|
2024
Q1 | $10.7M | Buy |
156,209
+2,114
| +1% | +$136K | 0.83% | 38 |
|
|
2023
Q4 | $8.91M | Buy |
154,095
+973
| +0.6% | +$51.9K | 0.76% | 41 |
|
|
2023
Q3 | $8.08M | Sell |
153,122
-584
| -0.4% | -$30.6K | 0.77% | 42 |
|
|
2023
Q2 | $8.31M | Sell |
153,706
-467
| -0.3% | -$24.4K | 0.74% | 42 |
|
|
2023
Q1 | $7.71M | Sell |
154,173
-268
| -0.2% | -$12.6K | 0.71% | 44 |
|
|
2022
Q4 | $7.15M | Sell |
154,441
-3,464
| -2% | -$150K | 0.66% | 47 |
|
|
2022
Q3 | $6.12M | Sell |
157,905
-2,726
| -2% | -$109K | 0.61% | 51 |
|
|
2022
Q2 | $5.99M | Sell |
160,631
-1,582
| -1% | -$64.4K | 0.56% | 50 |
|
|
2022
Q1 | $7.18M | Buy |
162,213
+2,449
| +2% | +$106K | 0.57% | 54 |
|
|
2021
Q4 | $6.79M | Sell |
159,764
-7,358
| -4% | -$309K | 0.53% | 56 |
|
|
2021
Q3 | $7.25M | Sell |
167,122
-1,612
| -1% | -$71.3K | 0.61% | 52 |
|
|
2021
Q2 | $7.21M | Sell |
168,734
-256
| -0.2% | -$10.8K | 0.62% | 50 |
|
|
2021
Q1 | $6.53M | Sell |
168,990
-4,037
| -2% | -$153K | 0.61% | 47 |
|
|
2020
Q4 | $6.22M | Sell |
173,027
-18,077
| -9% | -$652K | 0.61% | 45 |
|
|
2020
Q3 | $7.3M | Sell |
191,104
-132
| -0.1% | -$5.09K | 0.76% | 44 |
|
|
2020
Q2 | $6.71M | Buy |
191,236
+4,512
| +2% | +$162K | 0.82% | 38 |
|
|
2020
Q1 | $6.09M | Buy |
186,724
+10,825
| +6% | +$423K | 0.9% | 33 |
|
|
2019
Q4 | $7.95M | Buy |
175,899
+6,621
| +4% | +$277K | 0.92% | 33 |
|
|
2019
Q3 | $6.89M | Sell |
169,278
-10,280
| -6% | -$436K | 0.86% | 38 |
|
|
2019
Q2 | $7.72M | Buy |
179,558
+1,972
| +1% | +$75.8K | 0.89% | 37 |
|
|
2019
Q1 | $6.82M | Buy |
177,586
+5,541
| +3% | +$212K | 0.7% | 50 |
|
|
2018
Q4 | $6.08M | Buy |
172,045
+61,769
| +56% | +$2.24M | 0.7% | 54 |
|
|
2018
Q3 | $4.25M | Buy |
+110,276
| New | +$3.85M | 0.44% | 78 |
|
Other funds holding BSX
SouthState Corp's BSX Position: Q2 2026 in Review
SouthState Corp reduced its Boston Scientific (BSX) stake by 49% in Q2 2026, selling an estimated $4.65M and leaving 89,438 shares worth $3.82M. The position accounts for 0.16% of the portfolio, ranked #115.
SouthState Corp first reported a position in BSX in Q3 2018 and has held it in 32 quarters since. The position peaked at $18M in Q2 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- SouthState Corp held 89,438 shares of Boston Scientific worth $3.82M as of Q2 2026.
- SouthState Corp sold 85,634 Boston Scientific shares in Q2 2026, an estimated $4.65M.
- Boston Scientific made up 0.16% of SouthState Corp's portfolio in Q2 2026, its #115 holding.
- SouthState Corp first reported a position in Boston Scientific in Q3 2018 and has held it in 32 quarters since.
- SouthState Corp's Boston Scientific position peaked at $18M in Q2 2025.
- 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on SouthState Corp's 13F filing for Q2 2026, filed 6 Aug 2026.